A Standardized Plaque Reduction Assay for Determination of Drug Susceptibilities of Cytomegalovirus Clinical Isolates

Twelve laboratories collaborated in formulating and testing a standardized plaque reduction assay for cytomegalovirus (CMV) cell-associated clinical isolates. Four characterized and plaque-purified CMV strains, as well as six coded clinical isolates obtained after antiviral therapy, were distributed...

Description complète

Détails bibliographiques

Publié dans:	Antimicrob Agents Chemother
Auteurs principaux:	Landry, Marie L., Stanat, Sylvia, Biron, Karen, Brambilla, Donald, Britt, William, Jokela, Janet, Chou, Sunwen, Drew, W. Lawrence, Erice, Alejo, Gilliam, Bruce, Lurain, Nell, Manischewitz, Jody, Miner, Richard, Nokta, Mostafa, Reichelderfer, Patricia, Spector, Stephen, Weinberg, Adriana, Yen-Lieberman, Belinda, Crumpacker, Clyde
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Microbiology (ASM) 2000
Sujets:	Antiviral Agents
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89747/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10681339/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.3.688-692.2000
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!